Although earlier reports of this agent’s effectiveness were based primarily on lymphomas and other autoimmune diseases, recent studies have reported promising results in terms of eradicating FVIII inhibitors at a common dose of 375 mg/m2/week for up to 4 weeks [10]. The gene discussed is F8; the disease is lymphoma.